Bazhenova L, Hodgson JG, Camidge DR, Langer CJ, et al. Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status. Clin Lung Cancer 2025 Jun 6:S1525-7304(25)00128.
PMID: 40582920